N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine | CAS No. 2030-63-9
Basic Information
![N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine](/structs/203/2030-63-9-f3d9.webp)
CAS Number
2030-63-9
Molecular Formula
C27H22Cl2N4
Molecular Weight
473.41 g/mol
Quick Actions
Basic Physical Properties
Melting Point
210-213°C
Boiling Point
616.26°C (rough estimate)
Flash Point
296.7°C
Refractive Index
1.6300 (estimate)
Classification & Uses
Chemical Classification
Safety Information
View Safety InformationHazard Statement
H315; H319; H335
Toxicity
LD50 orally in mice, rats, and guinea pigs: >4 g/kg (Stenger)
Synonyms & References
English
- Phenazine, 3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-
- B663
- SR-05000001807-1
- 2-Phenazinamine,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
- N,5-Bis(4-chlorophenyl)-3-([1-methylethyl]imino)-3,5-dihydro-2-phenazinamine #
- N,5-bis(4-chlorophenyl)-3-propan-2-ylimino-phenazin-2-amine
- DTXSID7022839
- GTPL9184
- SCHEMBL26757
- 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine
- HY-B1046
- C2866
- NCGC00016600-02
- CLOFAZIMINE [ORANGE BOOK]
- B 663 (VAN)
- HMS3370N05
- AMY22515
- HMS3713K13
- Lamprene (TN)
- CLOFAZIMINE [USAN]
- J-013203
- G-30320
- AKOS026749881
- BRD-K56614220-001-10-9
- B. 663
- NC00409
- Pharmakon1600-01505974
- SMR000058704
- Phenazine, 2,10-dihydro-3-(p-chloroanilino)-10-(p-chlorophenyl)-2-(isopropylimino)-
- Chlofazimine
- C06915
- cid_2794
- (3E)-N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine
- DB00845
- 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin [German]
- NS00011720
- N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine
- 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin
- 2030-63-9
- CLOFAZIMINE [VANDF]
- CHEMBL1083384
- CLOFAZIMINE [USP-RS]
- Tox21_110516
- HMS3652A16
- HMS2052B05
- (3Z)-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine
- Prestwick0_000376
- SCHEMBL26758
- Clofazimine, European Pharmacopoeia (EP) Reference Standard
- 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-
- NSC-141046
- MLS006010789
- B 663, pharmaceutical
- Clofazimine for system suitability, European Pharmacopoeia (EP) Reference Standard
- HMS2096K13
- CLOFAZIMINE [EP MONOGRAPH]
- HMS3394B05
- EINECS 217-980-2
- KS-1412
- CLOFAZIMINE [INN]
- MLS000028617
- MMV687800
- NCGC00016600-07
- NCGC00016600-09
- SR-05000001807-2
- MLS001424318
- Clofazimine [USAN:USP:INN:BAN]
- SR-01000000259-6
- N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine
- 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine
- CLOFAZIMINE [USP IMPURITY]
- 2-Phenazinamine,5-dihydro-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-
- Prestwick2_000376
- CCG-269477
- BCP07792
- CLOFAZIMINE [JAN]
- NSC-759283
- SMR004701474
- Clofazimine 100 microg/mL in Acetonitrile
- Phenazine,10-dihydro-2-(isopropylimino)-
- N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-2-phenazinamine
- 2458811-14-6
- B-663
- N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine
- BIDD:PXR0147
- Phenazine,10-dihydro-3-(p-chloroanilino)-10-(p-chlorophenyl)-2-(isopropylimino)-
- Clofaziminum
- (4-Chloro-phenyl)-[5-(4-chloro-phenyl)-3-isopropylimino-3,5-dihydro-phenazin-2-yl]-amine
- Prestwick3_000376
- 2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)-
- 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine
- NCGC00179529-01
- D959AE5USF
- Clofazimina
- CPD000058704
- UNII-D959AE5USF
- SPBio_002452
- BSPBio_000531
- N,5-bis(4-chlorophenyl)-3-propan-2-ylimino-2-phenazinamine
- NCGC00016600-08
- Q418611
- G 30320
- KUC109573N
- SR-05000001807
- HMS2093J10
- KSC-27-052A
- 2-Phenazinamine,N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
- COLFAZIMINE [VANDF]
- FT-0657414
- NCGC00016600-04
- D00278
- BDBM50378783
- NSC759283
- Clofazimina [INN-Spanish]
- (3E)-N,5-bis(4-chlorophenyl)-3-isopropylimino-phenazin-2-amine
- s4107
- (E)-N,5-bis(4-chlorophenyl)-3-(isopropylimino)-3,5-dihydrophenazin-2-amine
- B 663
- Prestwick_685
- EN300-267815
- AKOS015896438
- Lamprene
- SW196840-4
- CLOFAZIMINE [WHO-IP]
- BPBio1_000585
- BDBM50318909
- 4-25-00-03033 (Beilstein Handbook Reference)
- EN300-21680301
- SR-01000000259
- CAS-2030-63-9
- CLOFAZIMINE [MI]
- Clofazimine, United States Pharmacopeia (USP) Reference Standard
- SBI-0206865.P001
- Lampren
- Riminophenazine
- HMS1569K13
- CLOFAZIMINE [WHO-DD]
- WDQPAMHFFCXSNU-KRUMMXJUSA-N
- SMP2_000339
- N,5-bis(4-chlorophenyl)-3-(isopropylimino)-3,5-dihydrophenazin-2-amine
- N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine
- Prestwick1_000376
- CCG-101159
- NSC 141046
- CLOFAZIMINUM [WHO-IP LATIN]
- Clofaziminum [INN-Latin]
- Clofazimine (JAN/USP/INN)
- 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
- CS-4567
- CLOFAZIMINE [USP MONOGRAPH]
- DTXCID302839
- A814428
- clofazimine
- HMS2231B04
- Z2037279473
- 2-p-Chloranilino-5-p-chlorphenyl-3,5-dihydro-3-isopropylimino-phenazin
- Colfazimine
- SCHEMBL5663361
- NSC141046
- B 663 (Pharmaceutical)
- NCGC00016600-03
- NCGC00016600-01
- MFCD00056793
- BRN 0060420
- N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropyliaino)phenazin-2-amine
- CHEMBL1292
- CHEBI:3749
- CLOFAZIMINE [MART.]
- NCGC00016600-05
- Clofazimine
- Clofazimine-d7
- 2-(4-Chlor-anilino)-5-(4-chlor-phenyl)-3-isopropylamino-phenazinium-betain
- 2-(4-chloro-anilino)-5-(4-chloro-phenyl)-3-isopropylamino-phenazinium-betaine
- Clo
- Clofazimine (N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine
MDL_Number
MFCD00056793
CAS Number
2030-63-9
Customs_Code
35040000
Merck_Index
2373
Supplier Information
Supplier Name | Member Level | Authentication Status | Main Category | MOQ | Action |
---|---|---|---|---|---|
Related Compounds
Related Articles
Microscopic insights into long-range 1D ordering in a dense semi-disordered molecular overlayer
Ryan T. Hannagan, Isaac Onyango, Amanda Larson, E. Charles H. Sykes
DOI: 10.1039/D1CC01574E
Increasing efficiency of perovskite solar cells using low concentrating photovoltaic systems
Hasan Baig, Hiroyuki Kanda, Abdullah M. Asiri, Mohammad Khaja Nazeeruddin, Tapas Mallick
DOI: 10.1039/C9SE00550A
A robust multifunctional ligand-controlled palladium-catalyzed carbonylation reaction in water
Kan Zhang, Ming-Ming Yang, Shan Xu, Hua-Ming Sun, Jin-Lei Zhang, Zi-Wei Gao, Wei-Qiang Zhang
DOI: 10.1039/C8CC00324F
Catalytic depolymerization of Kraft lignin to produce liquid fuels via Ni–Sn metal oxide catalysts
Baikai Zhang, Wenzhi Li, Xiaomeng Dou, Jindong Wang, Lele Jin, Ajibola T. Ogunbiyi, Xiaosen Li
DOI: 10.1039/C9SE01089K
Small size yet big action: a simple sulfate anion templated a discrete 78-nuclearity silver sulfur nanocluster with a multishell structure
Li-Ping Cheng, Zhi Wang, Qiao-Yu Wu, Hai-Feng Su, Tao Peng, Geng-Geng Luo, Yan-An Li, Di Sun, Lan-Sun Zheng
DOI: 10.1039/C8CC00014J
Triboelectric nanogenerators for a macro-scale blue energy harvesting and self-powered marine environmental monitoring system
Huamin Chen, Chao Xing, Yuliang Li, Jun Wang
DOI: 10.1039/C9SE01184F
Direct arylation polycondensation towards water/alcohol-soluble conjugated polymers as the electron transporting layers for organic solar cells
Qingwu Yin, Zhenfeng Wang, Boming Xie, Fei Huang, Yong Cao
DOI: 10.1039/D1CC01128F
Engineering of electrodeposited binder-free organic-nickel hydroxide based nanohybrids for energy storage and electrocatalytic alkaline water splitting
Rohit G. Jadhav, Devraj Singh, Shaikh M. Mobin, Apurba K. Das
DOI: 10.1039/C9SE00483A
Biomimetic hydrogels designed for cartilage tissue engineering
Alexander Stokes, Piergiorgio Gentile, Ana M. Ferreira
DOI: 10.1039/D0BM01852J